Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.
Journal: JAMA network open
Published: November 04, 2025
The Critical Difference Between Understanding and Consent: Lessons From Germline and Somatic Testing for Metastatic Prostate Cancer.
Journal: JCO oncology practice
Published: September 25, 2025
Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer.
Journal: Seminars in oncology
Published: March 06, 2024
Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.
Journal: Cancer investigation
Published: February 05, 2024
Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 15, 2023
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses.
Journal: EBioMedicine
Published: June 27, 2023
Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy.
Journal: Urologic oncology
Published: September 26, 2022
Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances.
Journal: Cancers
Published: September 07, 2021
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 14, 2020
Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage.
Journal: Reviews in urology
Published: February 20, 2020
The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy.
Journal: World journal of urology
Published: September 18, 2019
Last Updated: 09/26/2026